What is CVE-2022-38802?

CVE-2022-38802 is a medium-severity vulnerability in Zkteco Biotime, classified under Cross-site Scripting. CVSS score: 6.2/10. Published 2022-11-30.

How severe is CVE-2022-38802?

Medium severity. CVSS v3 base score is 6.2 out of 10.

XSS in Zkteco Biotime

CVE-2022-38802

Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via resign, private message, manual log, time interval, attshift, and holiday. An authenticated administrator can read local files by exploiting XSS into a…

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.006 (46.6th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.2 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:R/S:C/C:H/I:N/A:N.

Affected products

Zkteco Biotime
N/a — versions n/a

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cve@mitre.org (Product)
cve@mitre.org (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2022-38802?: CVE-2022-38802 is a medium-severity vulnerability in Zkteco Biotime, classified under Cross-site Scripting. CVSS score: 6.2/10. Published 2022-11-30.
How severe is CVE-2022-38802?: Medium severity. CVSS v3 base score is 6.2 out of 10.